Cargando…

Gut microbiota, key to unlocking the door of diabetic kidney disease

This review discusses the influence of gut microbiota dysbiosis on diabetic kidney disease through metabolite profile changes and immune and inflammatory mechanisms. We also elaborate on the mechanism of dysbiosis in the onset and development of other kidney diseases.

Detalles Bibliográficos
Autores principales:	Wang, Peipei, Wang, Ting, Zheng, Xuejun, Cui, Wen, Shang, Jin, Zhao, Zhanzheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360003/ https://www.ncbi.nlm.nih.gov/pubmed/33715272 http://dx.doi.org/10.1111/nep.13874

Ejemplares similares

Sacubitril/Valsartan contributes to improving the diabetic kidney disease and regulating the gut microbiota in mice
por: Wang, Peipei, et al.
Publicado: (2022)

Many Keys Unlock the Doors for Virus Entry
por: Gallagher, Tom
Publicado: (2022)

Variation of Serum Uric Acid Is Associated With Gut Microbiota in Patients With Diabetes Mellitus
por: Zhang, Weifeng, et al.
Publicado: (2022)

SGLT2 inhibitors suppress epithelial–mesenchymal transition in podocytes under diabetic conditions via downregulating the IGF1R/PI3K pathway
por: Guo, Ruixue, et al.
Publicado: (2022)

Corrigendum: SGLT2 inhibitors suppress epithelial-mesenchymal transition in podocytes under diabetic conditions via downregulating the IGF1R/PI3K pathway
por: Guo, Ruixue, et al.
Publicado: (2022)

Identification and validation of key biomarkers for the early diagnosis of diabetic kidney disease
por: Yu, Wei, et al.
Publicado: (2022)

A Special Key for Unlocking the Door to Targeted Therapies of Breast Cancer
por: Lindemann, Kristina, et al.
Publicado: (2008)

FG-4592 relieves diabetic kidney disease severity by influencing metabolic profiles via gut microbiota reconstruction in both human and mouse models
por: Jiang, Yumin, et al.
Publicado: (2023)

Midlife renewal: unlock the hidden door
por: Forson, James
Publicado: (2018)

Pattern recognition receptors in companion and farm animals – The key to unlocking the door to animal disease?
por: Werling, Dirk, et al.
Publicado: (2007)

Conquering communication in organisations: unlock the hidden door
por: Scher, Marion
Publicado: (2018)

Gut Microbiome Analysis Can Be Used as a Noninvasive Diagnostic Tool and Plays an Essential Role in the Onset of Membranous Nephropathy
por: Shang, Jin, et al.
Publicado: (2022)

Unlocking an acute psychiatric ward: open doors, absent patients?
por: Smith, Damian, et al.
Publicado: (2018)

Characterization and diagnostic value of the gut microbial composition in patients with minimal change disease
por: Zhang, Yiding, et al.
Publicado: (2022)

The gut microbiome in differential diagnosis of diabetic kidney disease and membranous nephropathy
por: Yu, Wei, et al.
Publicado: (2020)

Development and validation of a predictive model for the progression of diabetic kidney disease to kidney failure
por: Cheng, Yaqi, et al.
Publicado: (2020)

Unlocking Doors without Keys: Activation of Src by Truncated C-terminal Intracellular Receptor Tyrosine Kinases Lacking Tyrosine Kinase Activity
por: Mezquita, Belén, et al.
Publicado: (2014)

Unlocking the Door of Boosting Biodirected Structures for High‐Performance VN(x)O(y)/C by Controlling the Reproduction Mode
por: Li, Ting, et al.
Publicado: (2020)

A Minimal Genetic Passkey to Unlock Many Legume Doors to Root Nodulation by Rhizobia
por: Unay, Jovelyn, et al.
Publicado: (2020)

The harmful intestinal microbial community accumulates during DKD exacerbation and microbiome–metabolome combined validation in a mouse model
por: Shang, Jin, et al.
Publicado: (2022)

Gut microbiota and diabetic kidney diseases: Pathogenesis and therapeutic perspectives
por: Lin, Jia-Ran, et al.
Publicado: (2022)

Unlocking the Door to Neuronal Woes in Alzheimer’s Disease: Aβ and Mitochondrial Permeability Transition Pore
por: Du, Heng, et al.
Publicado: (2010)

Identification of key lncRNAs contributing to diabetic nephropathy by gene co-expression network analysis
por: Shang, Jin, et al.
Publicado: (2019)

Untargeted serum metabolomics and tryptophan metabolism profiling in type 2 diabetic patients with diabetic glomerulopathy
por: Zhang, Fanliang, et al.
Publicado: (2021)

Collaboration: the key to unlocking exotic nuclei
Publicado: (2010)

Four keys to unlock IgG
por: Nimmerjahn, Falk, et al.
Publicado: (2021)

Enterorenal crosstalks in diabetic nephropathy and novel therapeutics targeting the gut microbiota: Gut-kidney axis in diabetic nephropathy
por: Ni, Yinhua, et al.
Publicado: (2022)

Volunteers: the key that opens the doors for the Open Days
por: Antonella Del Rosso
Publicado: (2013)

Toll-like receptors: the key to the stable door?
por: Hopkins, Philip, et al.
Publicado: (2002)

Hidden keys in stroma: Unlocking the tumor progression
por: Astekar, Madhusudan, et al.
Publicado: (2013)

Characteristics of Serum Metabolites and Gut Microbiota in Diabetic Kidney Disease
por: Zhang, Bo, et al.
Publicado: (2022)

Development and validation of diagnostic models for immunoglobulin A nephropathy based on gut microbes
por: Dong, Yijun, et al.
Publicado: (2022)

From gut microbiota to host appetite: gut microbiota-derived metabolites as key regulators
por: Han, Hui, et al.
Publicado: (2021)

Combination of the gut microbiota and clinical indicators as a potential index for differentiating idiopathic membranous nephropathy and minimal change disease
por: Jiang, Yumin, et al.
Publicado: (2023)

Unlocking gut microbiota potential of dairy cows in varied environmental conditions using shotgun metagenomic approach
por: Khan, Faheem Ahmed, et al.
Publicado: (2023)

The Specific Alteration of Gut Microbiota in Diabetic Kidney Diseases—A Systematic Review and Meta-Analysis
por: Wang, Yuwei, et al.
Publicado: (2022)

The Linker Pivot in Ci-VSP: The Key to Unlock Catalysis
por: Hobiger, Kirstin, et al.
Publicado: (2013)

Could Mathematics be the Key to Unlocking the Mysteries of Multiple Sclerosis?
por: Weatherley, Georgia, et al.
Publicado: (2023)

Biomaterials are the key to unlock spheroid function and therapeutic potential
por: Ramos-Rodriguez, David H., et al.
Publicado: (2023)

The role and mechanism of the gut microbiota in the development and treatment of diabetic kidney disease
por: Wu, Xiaofang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k7c229n5aeqjt38fjs54ijcjis